Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solifenacin for OAB in Prostate Radiation Therapy
NCT01777217Phase 4Terminated
- Start
- Feb 2013
- Primary completion
- Jan 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of solifenacin in overactive bladder (OAB). Started Feb 2013; status: terminated.
02
Drugs
solifenacin
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT01777217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01777217.